XLIE SCIE |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | -.--% |
| 04-23 | Xlife Sciences Posts Higher FY23 Profit; Revenue Falls | MT |
| 02-29 | Xlife Sciences AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Evolution of the average Target Price on XLIE SCIE
Price target over the last 5 years
History of analyst recommendation changes
5623e4965c21cc5acad7d9.NaZmdgKQ560ay-cJ_EsONAZVnnWA_jgYiXzru5pz2rw.X_5fOWDjr-x7hpRziz5Bd0E0zSPKjWh8wBmm1vdCvM9Hwxc8eNGl2F6Cog~80a0ca49ab7791b7ce659f6eedd860f3
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
32
CHF
Average target price
68
CHF
Spread / Average Target
+112.50%
High Price Target
68
CHF
Spread / Highest target
+112.50%
Low Price Target
68
CHF
Spread / Lowest Target
+112.50%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
Annual profits - Rate of surprise
- Stock Market
- Equities
- XLS Stock
- XLSCF Stock
- Consensus XLIE SCIE
